H.R. 6482 · 116th Congress
Protecting Our Pharmaceutical Supply Chain from China Act of 2020
- Stage
- In committee
- Sponsor
- Mike Gallagher
- Introduced
- 2020-04-10
- Latest action
- 2020-07-13 · Referred to the Subcommittee on Oversight and Investigations.
Summary
Protecting Our Pharmaceutical Supply Chain from China Act of 2020
This bill requires the federal government to maintain a registry of certain foreign-sourced drugs, prohibits federal health care programs from purchasing drugs containing Chinese ingredients, requires drugs to be labeled for country of origin, and offers domestic manufacturing facility tax incentives.